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Abstract
Research reveals a biased preference for natural versus synthetic drugs; however, this research is
based upon self-report and has not examined ways to reduce the bias. We examined these issues
in five studies involving 1,125 participants. In a Pilot Study (N = 110), participants rated the term
natural to be more positive than the term synthetic, which reveals a default natural-is-better
belief. In Studies 1 (N = 109) and 2 (N = 100), after a supposed personality study, participants
were offered a thank you “gift” of a natural or synthetic pain reliever. Approximately 86%
(Study 1) and 93% (Study 2) of participants chose the natural versus synthetic pain reliever,
which provide a behavioral choice confirmation of the natural drug bias. In Studies 3 (N = 350)
and 4 (N = 356), participants were randomly assigned to a control or experimental condition and
were asked to consider a scenario in which they had a medical issue requiring a natural versus
synthetic drug. The experimental condition included a stronger (Study 3) or weaker (Study 4)
rational appeal about the natural drug bias and a statement suggesting that natural and synthetic
drugs can be good or bad depending upon the context. In both studies, the natural bias was
reduced in the experimental condition, and perceived safety and effectiveness mediated this
effect. Overall, these data indicate a bias for natural over synthetic drugs in preferences and
behavioral choices, which might be reduced with a rational appeal.

Key Words: natural bias; natural; preference; synthetic; perception; drug choice; health behavior
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A Behavioral Confirmation and Reduction of the Natural versus Synthetic Drug Bias
The terms “natural” or “nature” are often used in product names and marketing materials.
For example, one can purchase Applegate’s Natural Beef Hot Dogs or Truvia’s Natural
Sweeteners. Manufacturers may use terms related to natural because people seem to assume that
natural products are better and safer than unnatural, synthetic, or artificial products. Researchers
have shown that people generally consider something to be natural when it lacks additives and
processing1,2. Rozin et al.3 showed that people preferred foods described as natural rather than
processed or human made. Research has also found a natural bias with such diverse items as
cigarettes4, cultured or grown meat5, perfumes6, soda7, and even hormone replacement therapy
among obstetricians and gynecologists8.
Rozin et al.3 and others9 find that a preference for natural items is based upon
instrumental and ideational factors. Instrumental factors focus on the attributes of an item (e.g., a
natural product is safer), whereas ideational factors focus on the inherent appeal of natural items,
such as the idea that they are morally better because they are linked to nature. For example,
participants rated natural versions of items such as cigarettes4 or drugs9 as safer than the nonnatural or synthetic versions. These ratings suggest that natural may be preferred in some cases
for instrumental reasons. Yet, the diversity of contexts in which natural is preferred suggests that
there is also a natural-is-better default belief that operates in some situations. This view may
coincide with the affect heuristic, or the notion that people’s decisions may be guided by their
emotions in an intuitive or automatic sense10 . For example, if people have positive feelings
associated with the term natural, this may guide them to process information about a natural
product in a biased way, or to choose natural even though it may not be the best choice. We
examine people’s feelings associated with the term natural in a Pilot Study.
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Meier and Lappas11 examined preferences for natural versus synthetic drugs in a medical
context. In a series of studies, they found that participants preferred a natural to a synthetic drug
for a hypothetical medical condition even though the drugs were described as equally effective
and safe. They found this preference for both minor and serious health conditions. Furthermore,
some participants even preferred a natural drug when it was described as less safe or less
effective than a synthetic drug. Additionally, natural drugs were perceived as safer but less
effective than synthetic drugs regardless of the safety and effectiveness information given.
The U.S. Food and Drug Administration12 does not regulate the term natural and it is
therefore used to mean different things13 such as organic, non-artificial, and derived from plants.
Yet, research has shown that it is a term that has positive attributes across European and North
American cultures2. Although natural products like drugs can be beneficial, it is inaccurate to
assume that anything labeled natural is better or safer. For example, botulinum toxin and arsenic
are natural, but highly deadly. The findings of Meier and Lappas11 are concerning given that
natural drugs, when marketed as supplements, are not always tested for safety and efficacy and
natural drugs have sometimes been shown to have significant toxicities14,15. Furthermore, a bias
in favor of natural drugs may have consequences for people’s medical decision making. For
example, people may choose a natural drug for a medical issue rather than a synthetic drug
prescribed by their doctor.
Overview of Studies, Data Statement, and Power Statement
We conducted five studies to examine three questions, (1) do people prefer natural over
synthetic in the absence of a context?; (2) does the natural drug bias occur in behavior?; and (3)
can we reduce the natural drug bias? In a Pilot Study, we sought to determine if people believed
the term natural is more positive than the term synthetic. In Studies 1 and 2, we sought to
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determine if the natural versus synthetic drug bias would occur in a behavioral encounter. Prior
work has been based upon hypothetical scenarios, but we used a behavioral decision to
determine if the bias is reliable. In Studies 3 and 4, we sought to determine if we could reduce
the natural drug bias using a rational appeal. All studies were approved either by the Gettysburg
College or Grand Valley State University Institutional Review Boards.
In all of our studies, we report all measures, conditions, data exclusions, and the manner
in which we determined sample sizes. We did not include any covariates in our analyses. All
study materials and data are available upon request to the first author.
In five studies examining the natural versus synthetic drug bias, Meier and Lappas
(2016)11 found medium to large effect sizes. In their Studies 1a, 1b, and 4, which found the
standard natural bias (e.g., would you choose a natural or synthetic drug?), the effect sizes found
were Cramer’s Phis = .58, .52, and .28 (for interpretation, .50 is large & .30 is medium16). In
their Studies 2 and 3, they found that manipulations related to safety and efficacy were
moderated by whether a drug was described as natural or synthetic (e.g., do people choose a
natural or synthetic drug when the natural drug is less safe or less effective?) and the effect sizes
for this moderation were medium, Cramer’s Phis = .26 and .33. While these studies are not
identical to our studies, they are the best effect size estimates available. In order to be
conservative, we chose the low end and used a medium effect size estimate (Cramer’s Phi = .30)
for our a priori power analyses since our hypotheses were tested with a Chi Square test in Studies
1 through 4. In the Pilot Study, we use a dependent-samples t test to examine the hypothesis and
we use a medium effect size again to estimate sample size, in this case d (a medium effect size
with d = .5016). These power analyses are presented in the respective sections of the Pilot Study,
Studies 1 and 2, and Studies 3 and 4.
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Pilot Study
We estimated sample size using a medium effect size (d = .5016). A dependent-samples t
test was used to examine the hypothesis that participants would rate “natural” to be more positive
than “synthetic”. We used G*Power 3.1 and found that a sample of 34 participants was required
to reach 80% power. We sought to be conservative and attempted to collect data from 100
participants.
Method
Participants
Participants were 110 individuals (47 females; 61 males 2 non-report) with a mean age of
33.86 (SD = 11.15) years. The majority of the participants self-identified as Caucasian (87 or
79.10%), and the remaining participants self-identified as Asian/Pacific Islander (14 or 12.70%),
Black (4 or 3.60%), mixed race (2 or 1.80%), Hispanic (1 or .90%), or unknown (1 or .90%).
One participant did not report race. We removed five participants who gave the same rating for
all words (leaving 105 participants).
Participants came from Amazon’s Mechanical Turk (MTurk), a crowdsourcing website
with thousands of individuals17,18. Participants from MTurk have been shown to be more
demographically diverse than typical college student samples and to produce data as reliable as
laboratory-based data11,17. We recruited people living in the U.S. who were 18 years of age or
older (using MTurk’s participant selection options). Participants were paid $0.35 for completing
the study.
Materials and Procedures
We told participants on the consent form that the purpose of the research “is to learn
about people's judgments and perceptions of common things”. Participants were also told “you
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will be asked to rate a number of words in terms of how negative or positive they are in
meaning.” Before the ratings started, participants were told to “please rate the words below in
terms of their negative or positive meaning”. Participants rated the valence (1 = very negative to
5 = neutral to 9 = very positive) of 17 words including natural and synthetic as well as filler
words unrelated to these domains in order to disguise our true interest (kiss, region, horror,
fireworks, hut, mistake, chart, dirty, fat, beach, cake, barrel, reward, garbage, & pour). Natural
and synthetic occurred in the 7th and 14th positions, counter-balanced across participants.
Participants were debriefed at the end of the study.
Results and Discussion
Participants rated natural (M = 6.78; SD = 1.28) as much more positive than synthetic (M
= 4.50; SD = 1.27), t(104) = 12.01, p < .001, d = 1.17. Additionally, the natural rating was
significantly above the neutral point of 5, t(104) = 14.29, p < .001, d = 1.39, while the synthetic
rating was significantly below the neutral point of 5, t(104) = -3.99, p < .001, d = -.39. The
remaining filler words were rated in a manner consistent with their expected meaning (e.g.,
garbage was rated as being more negative than kiss). These rating results for natural and
synthetic are consistent with a large normed word set that includes these terms19.
These results suggest that there is an inherent positive belief about natural in a contextfree situation. Additionally, the results show that the natural rating was three times farther from
the mid-point of the scale than the synthetic rating. Thus, one reason for a natural bias may be
due to a default natural-is-better default belief. In other words, people may prefer natural to
synthetic, whether the item is food, drugs, beauty products or anything else. In the remaining
studies, we specifically examine a behavioral confirmation (Studies 1 and 2) and attempted
reduction (Studies 3 and 4) of the natural drug bias.
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Study 1
In Studies 1 and 2, we estimated sample sizes using a medium effect size (Cramer’s Phi =
.30). A Chi-Square test goodness of fit was used to examine the hypothesis that participants
would be more likely to choose the natural versus synthetic pain reliever. We used G*Power 3.1
and found that a sample of 88 participants was required to reach 80% power. We again sought to
be conservative and attempted to collect data from at least 100 participants in each study.
Method
Participants
Participants were 109 individuals (75 females; 34 males) with a mean age of 22.10 (SD =
9.09) years. They were recruited from the campus of Gettysburg College in Pennsylvania, U.S.
The majority of the participants self-identified as Caucasian (90 or 82.60%), and the remaining
participants self-identified as Hispanic (10 or 9.20%), Asian/Pacific Islander (5 or 4.60%), or
Black (2 or 1.80%). Two (1.80%) participants selected an “other” category.
Materials and Procedure
Due to the inherent challenges of conducting an ethical study examining the actual
consumption of a natural versus synthetic drug, we focused on a behavioral choice that appeared
real. We contacted participants walking on campus under the guise of a personality study, but we
were really interested in whether people would accept a natural or synthetic pain reliever for
participating in a study. A research assistant was instructed to walk around campus and look for
potential participants who did not appear busy and were walking alone. Once a potential
participant was identified, the research assistant approached and said:
“I’m running a psychology study and was wondering if you had 5 minutes to complete a
simple questionnaire. I’ll give you a chocolate bar for participating.”
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If participants agreed to take part in the study, the research assistant gave the participant a
consent form to read and complete. Upon completion of the consent form, the research assistant
gave the participant a personality questionnaire with 20 items. This questionnaire was used to
reduce suspicions about the true purpose of the study, which was to determine if people would
select a natural or synthetic pain reliever. The research assistant gave participants privacy during
completion of this questionnaire by stepping back a few feet. When participants completed the
personality items, they turned the page over and completed demographic questions. Upon
completion of the questionnaire, the research assistant said:
“Thanks for completing the questionnaire. Here is the candy bar (research assistant
reached in a bag). Ahh, actually I forgot to tell you that our department has received
several free samples of new non-prescription pain relievers. We decided to give them
away to participants. We have two types, and we can give you one today for
participating. One is a synthetic drug created in the laboratory by scientists and the other
is a natural drug taken from a common plant. Which one would you like?”
We used the descriptions of natural and synthetic drugs created by Meier and Lappas11. We did
not have actual pain relievers, but we wanted to make participants believe they would be
receiving an actual drug. Although we have no way of knowing if participants viewed our cover
story as credible, it did place them in a real situation in which a choice was necessary. After
participants made a drug choice (no drug, natural, or synthetic), the research assistant debriefed
the participants by telling them the true nature of the study. Finally, the research assistant gave
participants a Hershey’s chocolate bar and recorded participants’ drug choices.
Results and Discussion
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An unbiased finding would be one in which participants chose the drugs at an equal rate
(50% for each drug) given that no additional information was provided. Figure 1 (left side)
illustrates the frequency of the three choices, no drug, natural drug, and synthetic drug. Sixty of
the 109 participants indicated that they did not want either of the drugs. We examined the data of
the remaining 49 participants. Forty-two participants or 85.71% of these 49 participants chose
the natural drug whereas 7 or 14.29% of these 49 participants chose the synthetic drug. This
difference was statistically different from a 50%-50% split and illustrates a strong natural drug
bias for a behavioral choice, 2 (1, N = 49) = 25.00, p < .001, Cramer’s Phi = .71.
In Study 2, we sought to replicate Study 1 with a different sample of participants from
another location in the U.S. Additionally, we wanted to address two potential issues. First, a
large number of participants did not choose a pain reliever in Study 1 and therefore it could be
that these participants differ in some way from participants who did choose a pain reliever,
making our effect larger than it may be in realty. Therefore, in Study 2, participants who did not
want a pain reliever were asked to tell us which one they would choose if they had to take one.
Although this question is hypothetical, it allows us to determine if these individuals differ from
those who chose a pain reliever. Second, the definitions of natural and synthetic used in Study 1
(a synthetic drug created in the laboratory by scientists; a natural drug taken from a common
plant) differed on multiple dimensions. For example, the terms “laboratory”, “scientists”, and
“common plant” were only used in one condition or the other. These differences could have led
participants to make a choice that had more to do with the terms rather than preferences related
to natural or synthetic. In Study 2, we used definitions for natural and synthetic that only varied
on one dimension: a synthetic drug created from ingredients NOT FOUND in nature versus a
natural drug created from ingredients FOUND in nature. Both definitions are identical except for
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the word “not”. This definition also coincides with what people believe natural means such as
lacking additives and processing1,2.
Study 2
Method
Participants
Participants were 100 individuals (71 females; 28 males; 1 reported neither male or
female) with a mean age of 20.35 (SD = 2.51) years. They were recruited from the campus of
Grand Valley State University in Michigan, U.S. The majority of the participants self-identified
as Caucasian (84 or 84%), and the remaining participants self-identified as Hispanic (6 or 6%),
Black (6 or 6%), Asian/Pacific Islander (2 or 2%), and American India/Alaskan Native (2 or
2%).
Materials and Procedure
We followed the same procedures from Study 1 and also used the same instructions and
materials with two exceptions. One, if participants said they did not want a pain reliever, we
asked them to tell us which one they would want (natural or synthetic) if they had to choose.
Two, we used new definitions of natural and synthetic in our description of the pain relievers:
“Thanks for completing the questionnaire. Here is the candy bar (research assistant
reached in a bag). Ahh, actually I forgot to tell you that our department has received
several free samples of new non-prescription pain relievers. We decided to give them
away to participants. We have two types, and we can give you one today for
participating. One is a synthetic drug made from ingredients not found in nature and one
is a natural drug made from ingredients found in nature. Which one would you like?”
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After participants made a drug choice, the research assistant debriefed the participants by telling
them the true nature of the study. Finally, the research assistant gave participants a Hershey’s
chocolate bar and recorded participants’ drug choices.
Results and Discussion
Figure 1 (right side) illustrates the frequency of the three choices, no drug, natural drug,
and synthetic drug. Eleven of the 100 participants indicated that they did not want either of the
drugs and were asked the follow-up question. We found that 10 or 90.91% of these 11
participants chose the natural drug, 2 (1, N = 11) = 7.36, p = .01, Cramer’s Phi = .82.
The remaining 89 participants chose a pain reliever. Eighty-three or 93.26% of these 89
participants chose the natural drug whereas 6 or 6.74% of these 89 participants chose the
synthetic drug. This difference was statistically different from a 50%-50% split and again
illustrates a strong natural drug bias for a consequential behavioral choice, 2 (1, N = 89) =
66.62, p < .001, Cramer’s Phi = .87.
This study replicates the findings from Study 1 with the new definitions and with
participants from a different location. We also showed that participants who did not choose a
drug still showed a strong natural drug bias when asked to make a choice. It appears that fewer
participants refused a drug in Study 2 (11%) compared to Study 1 (55.05%). It is impossible to
determine the exact reason for this apparent difference as there are a number of potential
possibilities: the change in participant location (liberal arts college in the Northeast U.S. versus
public university in the Midwest U.S.), the use of different research assistants, the change in
definitions, or some other unknown variable. We address this issue further in the General
Discussion section. In Studies 3 and 4, we used a hypothetical scenario-based design and sought
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to determine if we could reduce the natural drug bias with the inclusion of a randomly assigned
rational appeal.
Study 3
In Studies 3 and 4, we estimated sample sizes using a medium effect size (Cramer’s Phi =
.30). A 2 x 2 Chi-Square test for independence was used to examine the hypothesis that
participants would be less likely to choose a natural versus synthetic drug when given a rational
appeal. G*Power 3.1 does not offer a sample size estimate option for a Chi-Square test for
independence when examining an exact effect size. We therefore used estimates from a power
table for a Chi-Square test for independence16. This information revealed that 87 total
participants were needed to reach 80% power. Yet, because we knew that an attempt to reduce
the natural bias has not been conducted in the past, and a true effect size was unknown, we
sought to collect data from as many participants as possible given our financial resources. We
therefore attempted to collect data from at least 350 participants in Studies 3 and 4.
Method
Participants
Participants in Study 3 came from MTurk. We recruited people living in the U.S. who
were 18 years of age or older. Participants were paid $0.75 for their participation. Participants
were 350 individuals (178 males; 171 females; 1 queer) with a mean age of 34.63 (SD = 10.37)
years. The majority of the participants self-identified as Caucasian (275 or 78.60%), and the
remaining participants self-identified as Hispanic (25 or 7.10%), Asian/Pacific Islander (25 or
7.10%), Black (23 or 6.60%), American Indian/Alaskan Native (1 or .30%), or mixed (1 or
.30%). We removed 13 participants who stated that they completed a study before with questions
similar to the ones used in Studies 1 and 2. Therefore, we analyzed data from 337 participants.
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Materials and Procedure
Participants first gave informed consent and were then told that researchers were
interested in their judgments and perceptions about common things like drugs. Participants were
randomly assigned to one of two conditions using the scenarios previously published by Meier
and Lappas11. We used the definitions of natural and synthetic used in Study 1. In both
conditions, participants were told to:
“Imagine that you learn that you have a medical condition and you need to take a drug to
treat it. You have to choose between one of the two options shown below:


Option 1 is a synthetic drug created in the laboratory by scientists.



Option 2 is a natural drug taken from a common plant.”

Participants in the control condition received the above question without any additional details
and were simply asked to choose one of the two options. Participants in the experimental
condition also received the following rational appeal:
“Some people think natural substances are better than synthetic substances. However,
many scientists would agree that it is inaccurate to make this assumption. For example,
natural substances such as Botulinum Toxin and Arsenic are poisons that can cause death
when people are exposed to small amounts. Furthermore, synthetic substances are not
inherently bad. Tylenol and many Anti-Cancer Drugs are synthetic substances and are
beneficial for humanity. Overall, sometimes natural substances are good or bad and
sometimes synthetic substances are good or bad.”
We developed this appeal in collaboration with a Ph.D. synthetic and organic chemist to
ensure it was scientifically sound. The appeal was purposely written so that participants would
know that it is inaccurate to automatically choose a natural drug. After providing their choice and
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consistent with the work by Meier and Lappas11, participants were asked to rate their perceptions
of the safety and effectiveness of each drug using a 1 (not at all) to 9 (very) scale. Participants
also completed the Short Item Need for Cognition scale20, which was included for exploratory
purposes and was not part of the current project. Finally, participants completed demographic
questions and were debriefed.
Results and Discussion
An unbiased finding would be one in which participants chose the drugs at an equal rate
(50% for each drug) and perceived the drugs as similarly safe and effective. Yet, as found in
Meier and Lappas11, we predicted that in the control condition, participants would choose the
natural drug more frequently than the synthetic drug and would rate it as safer, but less effective.
However, we expected these effects to be reduced in the experimental condition. These
hypotheses were confirmed. As shown in Figure 2, participants selected the natural drug
significantly more frequently in the control condition (122 of 173 or 70.50% of participants)
compared to the experimental condition (71 of 164 or 43.30% of participants), χ2 (1, N = 337) =
25.51, p < .001, Cramer’s Phi = .28. Thus, the rational appeal reduced the natural drug bias. We
also examined drug choice within each condition separately. The drug choice was different from
a 50-50% split in the control condition, χ2 (1, N = 173) = 29.14, p < .001, Cramer’s Phi = .41, but
not in the experimental condition, χ2 (1, N = 164) = 2.95, p = .09, Cramer’s Phi = .13).
We next examined perceived safety for each drug as a function of condition (Note: one
participant did not complete the safety ratings). We conducted a mixed-model ANOVA with
condition (control versus experimental) as a between-participants variable and safety rating of
drug type (natural versus synthetic) as a within-participants variable. We found a main effect of
drug type such that overall, participants rated the natural drug as safer (M = 6.45; SD = 1.58)
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than the synthetic drug (M = 5.53; SD = 1.96), F(1, 334) = 44.79, p = < .001, η2p = .12. However,
this main effect was qualified by a significant interaction between condition and drug type, F(1,
334) = 19.78, p = < .001, η2p = .06. We conducted two paired-samples t tests to examine the
safety ratings of the natural versus synthetic drug for each condition. Participants in the control
condition rated the natural drug as safer (M = 6.82; SD = 1.49) than the synthetic drug (M = 5.32;
SD = 2.08), t(1, 172) = 7.68, p < .001, d = .58, but the difference in ratings in the experimental
condition between the natural (M = 6.06; SD = 1.58) and synthetic (M = 5.75; SD = 1.81) drugs
was not significant, t(1, 162) = 1.64, p = .10, d = .13. The main effect of condition was not
significant, F(1, 334) = 1.43, p = .23, η2p < .01. These results suggest that the experimental
manipulation reduced the safety-rating bias for natural drugs.
We next examined perceived effectiveness for each drug as a function of condition (Note:
two participants did not complete the effectiveness ratings). We conducted a mixed-model
ANOVA with condition (control versus experimental) as a between-participants variable and
effectiveness rating of drug type (natural versus synthetic) as a within-participants variable. We
found a main effect of drug type such that overall, participants rated the synthetic drug as more
effective (M = 6.67; SD = 1.67) than the natural drug (M = 5.99; SD = 1.58), F(1, 333) = 30.57, p
= < .001, η2p = .08. This main effect was qualified by a significant interaction between condition
and drug type, F(1, 333) = 4.87, p = .03, η2p = .01. We ran two paired-samples t tests to examine
the effectiveness ratings of the natural versus synthetic drug for each condition. Participants in
the control condition rated the synthetic drug as more effective (M = 6.54; SD = 1.77) than the
natural drug (M = 6.13; SD = 1.66), t(1, 172) = 2.14, p =.03, d = .16. Participants in the
experimental condition also rated the synthetic drug as more effective (M = 6.81; SD = 1.53)
than the natural drug (M = 5.85; SD = 1.47), t(1, 161) = 6.25, p < .001, d = .49, although the
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effect size was three times as large. The main effect of condition was not significant, F < 1.
These results suggest that the experimental manipulation increased the effectiveness rating of the
synthetic drug relative to the natural drug.
Finally, we examined safety and effectiveness ratings as potential mediators of the effect
between the manipulation and drug choice. In other words, might safety and effectiveness beliefs
be two potential reasons why the rational appeal reduced the choice of a natural drug? To
examine this question, we computed two difference scores by subtracting the synthetic drug
rating from the natural drug rating for both safety and effectiveness. Positive scores mean that
participants rated the natural drug as safer/more effective than the synthetic drug, and negative
scores mean that participants rated the synthetic drug as safer/more effective than the natural
drug. We used Mplus (version 8) to examine mediation and included both the safety and
effectiveness ratings difference scores in the model. The manipulation was coded as -1 (control
condition) and 1 (experimental condition) and drug choice was coded as 1 (synthetic drug) and 2
(natural drug). The results revealed that both difference scores were significantly related to the
manipulation (safety: β = -.24, p < .001; effectiveness: β = -.12, p = .03) and drug choice (safety:
β = .63, p < .001; effectiveness: β = .59, p < .001). In terms of mediation, the indirect effects of
safety (β = -.15, p < .001, 95% CI = -.21 to -.09) and effectiveness (β = -.07, p = .03, 95% CI = .13 to -.01) were both significant and different from zero. These indirect effects suggest that the
link between the manipulation and drug choice was partially driven by perceived safety and
effectiveness.
The results of Study 3 suggest that a rational appeal may reduce the natural drug bias and
two potential mechanisms appeared to be perceived safety and effectiveness. Yet, Study 3 had
some potential issues that we sought to address in Study 4. First, we used the new definitions for
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both the natural and synthetic drugs. Second, we used a different rational appeal that was neutral
in tone compared to the appeal used in Study 3, which favored the synthetic drug choice. We
made this second change to determine if the natural drug bias would be reduced with a less
heavy-handed appeal that made our hypothesis potentially less apparent to participants.
Study 4
Method
Participants
Participants in Study 4 came from MTurk. We recruited people living in the U.S. who
were 18 years of age or older. Participants were paid $0.50 for their participation. Participants
were 356 individuals (172 males; 182 females; 1 non-binary) with a mean age of 37.18 (SD =
13.12) years. The majority of the participants self-identified as Caucasian (260 or 73.00%), and
the remaining participants self-identified as Black (36 or 10.10%), Hispanic (21 or 5.90%),
American Indian/Alaskan Native (18 or 5.10%), Asian/Pacific Islander (16 or 4.50%), mixed (2
or .60%), or Arab (1 or .30%). As in Study 3, we removed participants who stated that they
completed a study before with questions similar to the ones used. Therefore, we removed data
from 55 participants leaving us with data from 301 participants.
Materials and Procedure
Participants first gave informed consent and were then told that researchers were
interested in their judgments and perceptions about common things like drugs. Participants were
randomly assigned to one of two conditions using the same procedures from Study 3 with
changes to the response options and rational appeal. In both conditions, participants were told to:
“Imagine that you learn that you have a medical condition and you need to take a drug to
treat it. You have to choose between one of the two options shown below:
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Option 1 is a synthetic drug created from ingredients NOT FOUND in nature.



Option 2 is a natural drug created from ingredients FOUND in nature.”

19

Participants in the control condition received the above question without any additional details
and were simply asked to choose one of the two options. Participants in the experimental
condition also received the following appeal:


“Some people have a bias when choosing between natural and synthetic drugs. Yet, it is
known that both natural and synthetic drugs may be either helpful or harmful. For
example, there are both natural and synthetic poisons that cause death when people are
exposed to small amounts. Furthermore, there are both natural and synthetic drugs that
are beneficial for human health. Overall, some natural drugs are good and some are bad,
and some synthetic drugs are good and some are bad.”
This rational appeal included a neutral tone between the benefits and costs of synthetic

and natural drugs. This change allowed us to determine if a neutral appeal would reduce the
natural drug bias as compared to the stronger appeal used in Study 3. After providing their
choice, participants also rated their perceived safety and effectiveness of each drug. Finally,
participants completed demographic questions and were debriefed.
Results and Discussion
An unbiased finding would be one in which participants chose the drugs at an equal rate
(50% for each drug) and perceived the drugs as similarly safe and effective. Yet, as found in
Study 3, we predicted that in the control condition, participants would choose the natural drug
more frequently than the synthetic drug and would rate it as safer, but less effective. However,
we expected these effects to be reduced in the experimental condition. As shown in Figure 3,
participants selected the natural drug significantly more frequently in the control condition (114
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of 142 or 80.30% of participants) compared to the experimental condition (113 of 159 or 71.10%
of participants), but this difference was not quite significant at the traditional level, χ2 (1, N =
301) = 3.43, p = .06, Cramer’s Phi = .11. The rational appeal appeared to reduce the natural drug
bias, but not significantly. We also examined drug choice within each condition separately. The
drug choice was different from a 50-50% split in the control condition, χ2 (1, N = 142) = 52.09, p
< .001, Cramer’s Phi = .61, and in the experimental condition, χ2 (1, N = 159) = 28.23, p < .001,
Cramer’s Phi = .42).
We next examined perceived safety for each drug as a function of condition. We
conducted a mixed-model ANOVA with condition (control versus experimental) as a betweenparticipants variable and safety rating of drug type (natural versus synthetic) as a withinparticipants variable. We found a main effect of drug type such that overall, participants rated the
natural drug as safer (M = 6.42; SD = 1.63) than the synthetic drug (M = 4.87; SD = 1.85), F(1,
299) = 141.54, p < .001, η2p = .32. However, this main effect was qualified by a significant
interaction between condition and drug type, F(1, 299) = 21.77, p < .001, η2p = .07. We
conducted two paired-samples t tests to examine the safety ratings of the natural versus synthetic
drug for each condition. Participants in the control condition rated the natural drug as safer (M =
6.54; SD = 1.72) than the synthetic drug (M = 4.33; SD = 1.84), t(141) = 10.09, p < .001, d = .86,
and participants in the experimental condition also rated the natural drug as safer (M = 6.32; SD
= 1.54) than the synthetic drug (M = 5.36; SD = 1.73), t(158) = 6.06, p < .001, d = .54, although
the effect size was smaller. The main effect of condition was also significant, F(1, 299) = 7.86, p
= .01, η2p =.03. This effect revealed that participants in the experimental condition gave higher
safety ratings overall (M = 5.84; SD = 1.26) than participants in the control condition (M = 5.43;
SD = 1.25). Overall, these effects suggest that the experimental condition reduced the safety-
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rating bias for natural drugs compared to the control condition as in Study 3, but the difference
between the safety rating of the natural and synthetic drugs was still significant in the
experimental condition.
We next examined perceived effectiveness for each drug as a function of condition. We
conducted a mixed-model ANOVA with condition (control versus experimental) as a betweenparticipants variable and effectiveness rating of drug type (natural versus synthetic) as a withinparticipants variable. None of the effects were significant at the traditional level, main effect of
drug type: F(1, 299) = .02, p = .89, η2p < .001, main effect of condition: F(1, 299) = 3.87, p =
.50, η2p = .01, and the interaction between drug type and condition: F(1, 299) = 3.70, p = .06, η2p
= .01. The means and standard deviations for each condition are shown here: control condition synthetic drug (M = 5.97; SD = 1.90) and natural drug (M = 6.23; SD = 1.66); experimental
condition - synthetic drug (M = 6.52; SD = 1.66) and natural drug (M = 6.29; SD = 1.65). The
results for effectiveness ratings do not follow from Study 3 or past work11.
Finally, as in Study 3, we examined safety and effectiveness ratings as potential
mediators of the effect between the manipulation and drug choice. We again computed two
difference scores by subtracting the synthetic drug rating from the natural drug rating for both
safety and effectiveness. We used Mplus (version 8) to examine mediation and included both the
safety and effectiveness ratings difference scores in the model. The manipulation was coded as 1 (control condition) and 1 (experimental condition) and drug choice was coded as 1 (synthetic
drug) and 2 (natural drug). The results revealed that both difference scores were significantly
related to the manipulation (safety: β = -.26, p < .001; effectiveness: β = -.11, p = .05) and drug
choice (safety: β = .48, p < .001; effectiveness: β = .55, p < .001). In terms of mediation, the
indirect effect of safety (β = -.12, p < .001, 95% CI = -.19 to -.05) was significantly different
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from zero, but the indirect effect of effectiveness (β = -.06, p = .06, 95% CI = -.12 to .01) was
not significantly different from zero although this effect was close to being significant at the
traditional level. These indirect effects replicate the pattern from Study 3 and suggest that the
link between the manipulation and drug choice may be partially driven by safety and
effectiveness.
General Discussion
The results of five studies revealed that participants were biased towards a natural drug in
both a behavioral decision and in a hypothetical scenario. The results of our studies both
replicate and extend past work11. For example, they conceptually replicate past work in showing
that participants have a strong bias for natural over synthetic drugs. Our studies extend previous
work by confirming the bias in a behavioral choice and by showing that the bias can be
eliminated with a rational appeal. We discuss these results more thoroughly below.
The Pilot Study revealed that participants rated the term natural as more positive than the
term synthetic. Such results suggest that natural is an inherently positive concept and may be one
reason why people seem to prefer natural drugs and other natural items in different contexts. It
would be informative to determine if the extent to which participants rate natural as positive and
synthetic as negative partially drives the natural drug bias.
Studies 1 and 2 appear to be the first studies to find a confirmation of the natural versus
synthetic drug bias in a behavioral choice context. Past research (and our Studies 3 and 4) has
been based upon hypothetical scenarios, which is necessary to some extent given the ethical
limitations with giving people drugs to consume. Therefore, a confirmation of the natural drug
bias at the behavioral level provides some evidence for the validity of studies involving
hypothetical scenarios. It is noteworthy that the bias found in Studies 1 and 2 was larger than the
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bias found in past studies using hypothetical scenarios11. These results might suggest that the
natural drug bias is even stronger when assessed in behavioral paradigms (although see the
discussion of the limitations of these studies below).
We attempted to reduce the natural drug bias in Studies 3 and 4 by randomly assigning
participants to a rational appeal that explained the bias. This appeal reduced the bias in both
studies, but only significantly in Study 3 (Study 4’s effect was marginal). Studies 3 and 4
differed in at least two ways: in Study 4, the new definitions were used as well as the more
balanced rational appeal. Creative designs that involve different manipulations such as having
participants read an ostensible science article about the natural drug bias may be able to reduce
the bias in other ways. Such work is important as we are unaware of any work that has attempted
to reduce the natural bias in the drug domain or any other domain. Furthermore, such work could
have implications for medication decisions and adherence to pharmacological regimens, not to
mention the thoughtless purchases of well-advertised natural supplements. A similar rational
appeal may be effective in reducing the natural bias found in other areas mentioned earlier such
as cigarettes, meat, perfume, and soda.
In Studies 3 and 4, the perception of the safety and effectiveness of natural and synthetic
drugs was affected by the rational appeal. The appeal reduced the safety rating of the natural
drug, but also boosted the effectiveness rating of the synthetic drug at least in Study 3.
Additionally, safety was a significant mediator in both studies and effectiveness was a significant
mediator in one study and marginally significant in the other. These findings suggest that
perceptions of safety and effectiveness might be mechanisms involved in both producing and
reducing the natural drug bias although we recognize that other mechanisms are possible. Of
note, Meier and Lappas11 also found that natural drugs were perceived as safer but less effective
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than synthetic drugs when all else was equal, and people still showed a natural drug bias. This
possible disconnect between safety and effectiveness should be examined. It appears that safety
might be most important to the natural drug bias and thus interventions to reduce the bias need
only focus on safety. Of course it may also depend on the context in relation to the medical
decision of interest. Future work will be necessary to fully examine this possibility as well as
other consequences that may result from a bias in favor of natural drugs.
Limitations
Our studies are not without limitations. First, it is possible that some participants did not
believe the cover story regarding pain relievers in Studies 1 and 2. Some participants may not
have believed that the research assistant actually had pain relievers to distribute. We are unable
to shed light on this possibility as we did not ask follow-up questions in regards to the
believability of the cover story. While it is not uncommon to receive free products when
participating in a study, future researchers should use a design that is less susceptible to this
criticism such as one in which two pain relievers are actually shown to participants (but not
actually given once a choice is made).
Second, it is possible that some of our designs introduced a demand characteristic or a
desire for participants to behave according to how they thought researchers wanted them to act.
Research has commonly asked people to choose or rate items described as natural versus
synthetic, artificial, processed, etc.1-7. Therefore, it seems unlikely that a choice task (natural
versus synthetic) introduced a demand response. Yet, the rational appeal used in Study 3 was
heavy handed against natural drugs and therefore may have led to a reduction in the bias due to a
demand explanation rather than due to an actual understanding of the natural versus synthetic
bias. Study 4 seems less likely to involve such a possibility given that the rational appeal was
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evenly balanced between natural and synthetic. Future researchers should consider demandrelated issues when designing manipulations to reduce the natural bias.
Conclusion
In five studies, we found that participants preferred a natural versus a synthetic drug in a
behavioral context and in hypothetical medical scenarios. The bias was reduced with a rational
appeal and perceived safety and effectiveness were possible mediators. The overall results
indicate that the bias for natural drugs is strong, but it may be reduced with a rational appeal.
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Fig. 1. Frequency of Drug Choice in Studies 1 and 2
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Fig. 2. Frequency of Drug Choice by Condition in Study 3
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Fig. 3. Frequency of Drug Choice by Condition in Study 4

30

